Patent ID: 9657080
Date: 2017-05-23
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method for treating a disease in a patient where inhibition of insulin-like growth factor 1 activity is desired, the method comprising administering to a patient in need thereof a therapeutically effective amount of a peptide comprising Gly-Ala-Ser-Asp-Ser-Asp-Val-Tyr-Asp-Leu-Leu-Ala-Gly-Ser-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Ser (SEQ ID NO: 3), a proteolysis-resistant peptide derived from SEQ ID NO: 3 by one or more chemical modifications, or a peptide derived from SEQ ID NO: 3 by one or more conservative substitutions and having more than 80% homology with SEQ ID NO: 3.